InsiderClue
Insiders · Profile

Goff Brian

Chief Executive Officer at AGIOS PHARMACEUTICALS. Filing since 30 Jun 2023. CIK 0001546216

Company
Date
Role
Action
Shares
Amount
Of holding
AGIO AGIOS PHARMACEUTICALS, INC.
2 Apr 2026
Chief Executive Officer
Sold on a plan
19,068
$661.85K
9.7%
AGIO AGIOS PHARMACEUTICALS, INC.
2 Mar 2026
Chief Executive Officer
Sold on a plan
18,055
$522.87K
10.9%
AGIO AGIOS PHARMACEUTICALS, INC.
30 Dec 2025
Chief Executive Officer
Sold on a plan
18,703
$506.66K
12.0%
AGIO AGIOS PHARMACEUTICALS, INC.
8 Aug 2025
Chief Executive Officer
Sold on a plan
11,085
$406.49K
8.2%
AGIO AGIOS PHARMACEUTICALS, INC.
24 Jun 2025
Chief Executive Officer
Sold on a plan
18,700
$627.20K
15.1%
AGIO AGIOS PHARMACEUTICALS, INC.
3 Mar 2025
Chief Executive Officer
Sold on a plan
12,947
$460.14K
13.5%
AGIO AGIOS PHARMACEUTICALS, INC.
8 Aug 2024
Chief Executive Officer
Sold on a plan
11,091
$474.14K
12.3%
AGIO AGIOS PHARMACEUTICALS, INC.
5 Jun 2024
Chief Executive Officer
Sold on a plan
12,115
$591.70K
15.3%
AGIO AGIOS PHARMACEUTICALS, INC.
5 Mar 2024
Chief Executive Officer
Sold on a plan
4,156
$135.36K
7.2%
AGIO AGIOS PHARMACEUTICALS, INC.
24 Jan 2024
Chief Executive Officer
Sold on a plan
7,635
$165.22K
13.4%
AGIO AGIOS PHARMACEUTICALS, INC.
9 Jan 2024
Chief Executive Officer
Sold on a plan
12,066
$277.40K
23.2%
AGIO AGIOS PHARMACEUTICALS, INC.
8 Aug 2023
Chief Executive Officer
Sold on a plan
10,178
$259.34K
27.7%
AGIO AGIOS PHARMACEUTICALS, INC.
30 Jun 2023
Chief Executive Officer
Sold on a plan
11,449
$324.69K
44.8%
13 decisions on file.